Pharmacological Effects and Toxicity Studies
Pharmacological Effects and Toxicity Studies is a research topic within Pediatrics, Perinatology and Child Health. Science Explorer counts 50k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the effects of prenatal exposure to antiepileptic drugs (AEDs) on neurodevelopment, teratogenicity, cognitive function, bone health, and oxidative stress. It also explores the impact of maternal epilepsy on fetal development and the association with neurodevelopmental disorders and malformations.
- Antiepileptic Drugs
- Prenatal Exposure
- Teratogenicity
- Neurodevelopmental Disorders
- Cognitive Function
- Malformations
- Bone Health
- Oxidative Stress
- Maternal Epilepsy
- Fetal Development
- Research works
- 50k fractional, since 1950
- In the world top 10%
- 5k per year above
- Top-10% rate
- 10.1% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- -2% the tick is no change
- Largest producer
United States
34% of the 10 largest, 2022-now
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Pharmacological Effects and Toxicity Studies research?
By volume, the United States and China publish the most (1.5k and 721 works in 2022-now).
By volume, 2022-now
- 1
United States 1.5k works
- 2
China 721 works
- 3
India 548 works
- 4
United Kingdom 307 works
- 5
Japan 274 works
- 6
Germany 259 works
- 7
Türkiye 247 works
- 8
Italy 198 works
- 9
France 186 works
- 10
Brazil 170 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Pharmacological Effects and Toxicity Studies research?
By volume in 2022-now, Harvard University publishes the most Pharmacological Effects and Toxicity Studies research, followed by All India Institute of Medical Sciences and University College London.
By volume, 2022-now
- 1
Harvard University
United States 58 works
- 2
All India Institute of Medical Sciences
India 44 works
- 3
University College London
United Kingdom 44 works
- 4
Sichuan University
China 35 works
- 5
Mayo Clinic
United States 29 works
- 6
University of Toronto
Canada 29 works
- 7
Inserm
France 28 works
- 8
Johns Hopkins University
United States 26 works
- 9
University of North Carolina at Chapel Hill
United States 24 works
- 10
Capital Medical University
China 23 works
Who are the leading researchers in Pharmacological Effects and Toxicity Studies?
The most-cited researchers publishing on Pharmacological Effects and Toxicity Studies include Simon Iain Hay, Theo Vos and George Davey Smith.
- 1
Simon Iain Hay
United States 452k citations
- 2
Theo Vos
United States 439k citations
- 3
George Davey Smith
United Kingdom 435k citations
- 4
John J.V. McMurray
United Kingdom 349k citations
- 5
Cyrus Cooper
United Kingdom 342k citations
- 6
Valery L. Feigin
New Zealand 341k citations
- 7
Giuseppe Remuzzi
Italy 328k citations
- 8
Graeme J. Hankey
Australia 316k citations
- 9
Gordon Henry Guyatt
Canada 315k citations
- 10
Gregory Y.H. Lip
United Kingdom 311k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Pharmacological Effects and Toxicity Studies research done?
The largest centres of Pharmacological Effects and Toxicity Studies research in 2022-now are London (United Kingdom), Beijing (China), Tokyo (Japan) and New York (United States).
Largest cities, 2022-now
- 1
London
United Kingdom 112 works
- 2
Beijing
China 89 works
- 3
Tokyo
Japan 80 works
- 4
New York
United States 73 works
- 5
Paris
France 69 works
- 6
Seoul
South Korea 65 works
- 7
Istanbul
Türkiye 61 works
- 8
New Delhi
India 59 works
- 9
Boston
United States 56 works
- 10
Melbourne
Australia 55 works
Where is the best place to study Pharmacological Effects and Toxicity Studies?
Among universities, judged by research, University College London, Harvard University and Karolinska Institutet score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Pharmacological Effects and Toxicity Studies, country by countryIs Pharmacological Effects and Toxicity Studies research growing?
Output in 2022-2025 was 2% lower than in 2018-2021, peaking in 2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Pharmacological Effects and Toxicity Studies as a percentage of every work published that year, 0.031% in 2024.
Fractional works of Pharmacological Effects and Toxicity Studies over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Pharmacological Effects and Toxicity Studies. Posts are plain text and can be reported.